acetaminophen has been researched along with Persistent Fetal Circulation Syndrome in 5 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Persistent Fetal Circulation Syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, C | 1 |
| Bussmann, N | 1 |
| Staunton, D | 1 |
| McCallion, N | 1 |
| Franklin, O | 1 |
| El-Khuffash, A | 1 |
| Bauer-Rusek, S | 1 |
| Samra, N | 1 |
| Moore, SS | 1 |
| Arnon, S | 1 |
| Nagano, N | 2 |
| Katayama, D | 2 |
| Imaizumi, T | 2 |
| Hijikata, M | 2 |
| Okahashi, A | 2 |
| Tsuji, Y | 2 |
| Morioka, I | 2 |
| Zhong, B | 1 |
| Tan, K | 1 |
| Razak, A | 1 |
| Sackett, V | 1 |
| Machipisa, C | 1 |
| Zhou, L | 1 |
| Samiee-Zafarghandy, S | 1 |
| Sehgal, A | 1 |
| Hunt, RW | 1 |
| Pharande, P | 1 |
| Malhotra, A | 1 |
| van den Anker, JN | 1 |
| Allegaert, K | 1 |
5 other studies available for acetaminophen and Persistent Fetal Circulation Syndrome
| Article | Year |
|---|---|
The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance.
Topics: Acetaminophen; Ductus Arteriosus, Patent; Gestational Age; Humans; Infant, Newborn; Infant, Prematur | 2022 |
Paracetamol Treatment for Patent Ductus Arteriosus, an Apparent Association with Acute Hemolysis in Three Preterm Infants: Case Series.
Topics: Acetaminophen; Ductus Arteriosus, Patent; Hemolysis; Humans; Ibuprofen; Infant, Newborn; Infant, Pre | 2022 |
Fluctuations in unbound bilirubin levels during acetaminophen therapy for patent ductus arteriosus.
Topics: Acetaminophen; Bilirubin; Ductus Arteriosus, Patent; Humans; Infant, Newborn; Infant, Premature; Per | 2023 |
Fluctuations in unbound bilirubin levels during acetaminophen therapy for patent ductus arteriosus.
Topics: Acetaminophen; Bilirubin; Ductus Arteriosus, Patent; Humans; Infant, Newborn; Infant, Premature; Per | 2023 |
Fluctuations in unbound bilirubin levels during acetaminophen therapy for patent ductus arteriosus.
Topics: Acetaminophen; Bilirubin; Ductus Arteriosus, Patent; Humans; Infant, Newborn; Infant, Premature; Per | 2023 |
Fluctuations in unbound bilirubin levels during acetaminophen therapy for patent ductus arteriosus.
Topics: Acetaminophen; Bilirubin; Ductus Arteriosus, Patent; Humans; Infant, Newborn; Infant, Premature; Per | 2023 |
Early neurodevelopmental outcomes of extreme preterm infants exposed to paracetamol: a retrospective cohort study.
Topics: Acetaminophen; Birth Weight; Ductus Arteriosus, Patent; Female; Humans; Ibuprofen; Infant; Infant, N | 2023 |
Acetaminophen to Prevent Symptomatic Patent Ductus Arteriosus: Another Drug Bites the Dust?
Topics: Acetaminophen; Ductus Arteriosus, Patent; Dust; Humans; Infant, Newborn; Infant, Premature; Persiste | 2016 |